Comparison · NCT03409367-8f60a94e
Daily Emollient vs Natural Skin: Provider-diagnosed Atopic Dermatitis at 18 Months
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Daily Emollient vs Natural Skin: Provider-diagnosed Atopic Dermatitis at 18 Months. Trial comparisons, record NCT03409367-8f60a94e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03409367-8f60a94e
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.275 | 0.239 | 0.313 | wilson | |
| Risk in group 2 | 0.344 | 0.306 | 0.384 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0693 | -0.123 | -0.0155 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.798 | 0.67 | 0.952 | log | |
| Odds ratio, group 1 over group 2 | 0.722 | 0.56 | 0.93 | log | |
| Number needed to treat, for one fewer participant with the outcome on Daily Emollient than on Natural Skin | 14.4 | 8.15 | 64.7 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Daily Emollient | Parents assigned to the intervention arm receive a lipid-rich emollient and educational materials promoting once daily full-body emollient use until infant age 24 months. Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream: Lipid-rich emollient serving as skin barrier | 154 | 561 | OG000 |
| Group 2 | Natural Skin | Parents assigned to the control arm receive educational materials promoting general infant skin care guidelines only and asked to refrain from emollient use unless dry skin develops (current standard of care guidelines). | 196 | 570 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Provider-diagnosed Atopic Dermatitis at 18 Months
- Description
- Diagnosis of atopic dermatitis (eczema) recorded by primary care providers in health records up to 18 months of age.
- Time frame
- up to 18 months
- Population
Infants with diagnosis of atopic dermatitis at \<=18 months or with no diagnosis and at least one primary care visit in the health record after 15 months of age. Numbers represent participants according to arm randomized, regardless of adherence to study instructions.
Source ClinicalTrials.gov
Trial
- Title
- A Community-based Assessment of Skin Care, Allergies, and Eczema
- NCT number
- NCT03409367
- Phases
- NA
- Conditions
- Atopic Dermatitis, Atopic Disorders, Eczema, Atopic Eczema
- Interventions
- Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream
- Lead sponsor
- Oregon Health and Science University
- Results first posted
- 2025-08-15
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03409367?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03409367-8f60a94e